UK To Offer Firms More Flexible Commercial Deals On ‘Transformative’ Drugs, Earlier Access To Market

 
• By Ian Schofield

Companies seeking to have their innovative drugs made available on the NHS in England could benefit from government plans to offer “transformative” new products access to the market up to four years earlier than under the standard assessment route.

Access
Half a dozen products a year will gain early acces to market under UK government plans

More from Drug Pricing

More from Scrip